Boston-Brazil Collaborative Study of Sickle Cell Disease | NHLBI Trans-Omics for Precision Medicine Skip to main content

Boston-Brazil Collaborative Study of Sickle Cell Disease

Short Name
Boston-Brazil_SCD
Institution(s)
Harvard University
Type of Omics
WGS
Approx. Sample Size 958
Disease/Phenotype
sickle cell disease
Starting Phase
Phase 2
dbGaP ID
TOPMed Accession #
Please see this TOPMed Project's Parent Studies.
Omics Center(s) Phase 2
Baylor College of Medicine Human Genome Sequencing Center
Specify the TOPMed Phase for the Omics Center(s) selected above
Ph 5.4-5.5; 6 backfill
Omics Center Contact
Phases Involved
2
Populations
Brazilian
PI
Contact
Steering Committee Representatives
P&P primary
Project
Boston-Brazil_SCD
Released
No
Back to top